RxDoctor Payments Data

Bradford Waddell, MD

Orthopaedic Surgery · Dallas, TXNPI 1467689265

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $206,208 of the $324,814 with a category attached, or 63.5%. Smith+Nephew accounts for 87.6% of it on its own, with 3 other manufacturers making up the rest. Among orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$324,814in general payments, 2019–2025

Across 300 payments — averaging $1082.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$285K
  • Orthalign Inc$40K
  • Stryker$55
  • Johnson & Johnson$53
$117,463in research payments, 2019–2025

Across 8 payments — averaging $14,683 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Stryker$63K
  • Smith+Nephew$54K

What the payments were for

  • Consulting fees$206,20863%
  • Speaking & faculty fees$77,03024%
  • Travel & lodging$31,96310%
  • Food & beverage$9,6133%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew264$284,677
Orthalign Inc30$40,029
Stryker2$55
Johnson & Johnson4$53

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$324,814 in reported general payments places this provider in the 95th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$514,380
Medicare patients
672
Services billed
6,258

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl243$1,926
Ibuprofen175$1,898
Cefadroxil229$1,499
Ondansetron Hcl198$1,496
Omeprazole234$1,484
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen146$1,451
Mupirocin225$1,448
Celecoxib60$1,354
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen88$1,172
Diclofenac Sodium81$905
Pregabalin138$817
Etodolac13$389
Meloxicam98$359
Tramadol Hcl67$285
Gabapentin42$224

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →